SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001558370-22-002070
Filing Date
2022-02-25
Accepted
2022-02-25 09:28:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tmb-20220225x424b3.htm 424B3 1886055
2 GRAPHIC tmb-20220225x424b3002.jpg GRAPHIC 6951
  Complete submission text file 0001558370-22-002070.txt   1896896
Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-259336 | Film No.: 22674895
SIC: 2834 Pharmaceutical Preparations